The production of antibodies after immunization requires antigen recognition by B cells, expansion of the pool of antigen-reactive B cells, and finally, differentiation of these B cells into antibody-secreting plasma cells. Current models for this process of B cell maturation in humans involve separate signals for B cell activation, proliferation, and differentiation (1, 2). One ofthe lymphokines that has been shown to enhance B cell proliferation is a 50-60-kD product of activated T cells and of the Namalwa cell line termed high molecular weight B cell growth factor (HMW BCGF)t (3). Human HMW BCGF has been purified to homogeneity, and this molecule has no obvious analog among the B cell growth factors of mice .
lube F-50 (General Electric Co., New York, NY) at 12,500 g, following which, the cell pellet (bound ligand) and the supernatant (free ligand) were counted separately in a gamma counter. Specific binding was calculated as binding in tubes without excess cold Bb minus binding in tubes containing excess cold Bb. Under these conditions nonspecific binding represented 0.22 ± 0.01% of input cpm. All determinations were performed in duplicate.
Results
Effect of Bb on B Cell Function . Because of the possibility that Bb could affect immune responses (12) , we systemtically examined the effect of Factor B and its larger cleavage fragment, Bb, on cellular immune function . Preliminary data suggested that Bb did not influence T cell proliferation in response to PHA. Bb also did not influence activation of purified resting B cells. In the absence of activation of the B cells by SAC, Bb had little effect on subsequent proliferation (Fig . 1) . However, after the B cells had been activated with SAC, Bb markedly enhanced proliferation in a dose-dependent manner (Figs. 1 and 2 A) . On the other hand, intact Factor B had no effect on the proliferation ofunactivated or activated B cells (data not shown) . Bb also enhanced B cell proliferation in the presence of suboptimal HMW-BCGF concentrations in a dose-dependent manner (Fig. 2 B) . However, maximal proliferation in the presence of HMW-BCGF and Bb was no greater than in the presence of Bb alone (compare Fig. 2 A and B) or in the presence of optimal HMW-BCGF alone (data not shown), suggesting that the effects of HMW-BCGF and Bb were additive, and not synergistic. Since Bb enhanced only the proliferation of B cells that had been activated in vitro by SAC, we tested the effect of Bb on proliferation of in vivo preactivated B cells. These cells, which presumably have been stimulated by antigen in vivo, are large and can be isolated from smaller unstimulated B cells by counter-current elutriation (26) . As shown in Fig. 3 , Bb markedly enhanced proliferation of these larger activated B cells at concentrations >1 gg/ml (N17 nM), while its effect on smaller B cells was far less marked. Thus, the larger preactivated B cells are more susceptible to the effect of Bb. These data suggested a functional similarity between Bb and HMW-BCGF Like Bb, HMW-BCGF enhances proliferation of SAC-stimulated, or in vivo preactivated B cells, but has little effect on small unactivated B cells (29) . In addition, Bb had no effect on Ig production when added alone or with SAC, which is also similar to HMW-BCGF (29) . This, and the fact that Bb could not further enhance proliferation of B cells optimally stimulated with HMW BCGF suggested that the two proliferative stimuli might be acting through a similar mechanism.
This hypothesis suggested that the effect of Bb was directly on B cells rather than on monocytes, a previously described target of Bb action (13) . To test whether Bb acted indirectly on B cell proliferation via modulation of monocyte function, we performed two experiments. In one, monocytes were cultured for 4 and 24 h in the presence or absence of 10 wg/ml (170 nM) of Bb . Supernatants were harvested and then placed in culture with SAC-activated B cells. Monocyte supernatants with or without Bb stimulated SAC-activated B cell proliferation; thus, the effect of Bb could not be evaluated under these conditions . Therefore, we performed a second series of experiments in which monocytes were cultured overnight in the presence of Bb at 10 wg/ml (170 nM). After this preincubation the cells were washed and placed in culture with SAC-activated B cells. Preincubation of monocytes with and without Bb had similar effects on subsequent B cell [3H]Tdr incorporation (1,884 ± 227 and 1,331 ± 169 cpm, respectively), which was above unstimulated cultures (293 t 65) but less than optimally stimulated cultures (26,876 ± 1,633 cpm) . Thus, Bb did not enhance monocytes' ability to affect B cell proliferation.
Next, we evaluated the effect of the serine protease inhibitor NPGB on B cell proliferation induced by Bb . Because Bb's effect on macrophage spreading requires preservation of its serum esterase activity (21), we examined whether this was true for its enhancement of B cell proliferation. If the proteolytic activity of Bb were required, it might also be true that HMW-BCGF enhances proliferation via a protease ac- (Fig . 4 A) . Remarkably, HMW-BCGF also inhibited the binding of 1251_Bb to activated B cells, suggesting that Bb and HMW-BCGF bound to the same receptor on these cells. The unrelated molecules IgG and Ba did not affect the binding of 125I_ Bb. To ensure that this binding was to B cells rather than to contaminating macrophages, we also examined the binding of 1251-Bb to the EBVtransformed B cell line, MB (Fig . 4 B) . MB exhibits many of the surface characteristics of activated B cells, including expression of the receptor for HMWBCGF (27) . MB also bound Bb specifically, and as with activated untransformed B cells, this binding was inhibited by cold HMW-BCGF. Scatchard analysis of the saturable binding of Bb to SACactivated normal B cells and MB cells was performed. As shown in Fig. 5 , Bb bound to activated normal B cells with a Kd of 110 ± 19 nM (6.6 gg/ml) and there were 21,000 ± 3,500 sites per cell (mean ± SEM, n = 3). Analysis of binding to MB cells showed a sightly lower affinity (Kd: 152 ± 19 nM: 9 ug/ml) with more binding sites per cell (54,000 t 8,000, mean ± SEM, n = 4) . Together these data demonstrate that there is a Bb receptor on the activated B cells themselves, and that the Bb receptor is closely related or identical to the B cell receptor for HMW-BCGF. Factor Band Bb Are Antigenically Related to HMW-BCGF Because of the similarity in functional effect ofBb and HMW-BCGF, as well as their similar molecular weights and apparent crossinhibition of binding to B cells, we examined the two molecules for antigenic homology. We first probed with BCGFIC2, an mAb to HMW-BCGF, which inhibits its function (3) . As shown in Monoclonal anti-HMW-BCGF Inhibits the Proliferative Signal ofBb. The data obtained in the preceding studies suggested that Bb and HMW-BCGF might be homologous in a domain recognized by a B cell receptor important in signalling cellular proliferation. To test this directly, we used the mAb BCGFIC2, which inhibits HMWBCGF action on B cells (3), and which binds to Bb (see Fig. 6 ). As shown in Table 11 , BCGF- 1C2 inhibited Bb-induced proliferation of SAC-activated B cells in a dose-dependent manner. BCGF1C2 also inhibited proliferation induced by HMWBCGF. P3X, a control antibody, had no effect on Bb-induced proliferation when used at similar concentrations . Thus, BCGF1C2 recognized epitopes on both Bb and HMWBCGF, which are in proximity to sites required for their proliferative activity.
Because of the close relationship between Bb and HMW-BCGF in their effects on B cell function, we sought to determine whether HMW-BCGF could affect complement activation . However, the limited availability ofthis protein precluded direct experiments. BCGF1C2, which inhibits HMW-BCGF and Bb activity on B cells, did not affect C3b and Factor D-dependent Factor B cleavage or Bb-mediated C5 cleavage (data not shown) . 
Discussion
In this work we have examined the relationship between Bb, the 60-kD proteasecontaining activation fragment of complement Factor B, and HMW-BCGF, a welldescribed B cell growth factor (3). There is both antigenic and functional homology between these molecules. First, antibodies made against Factor B recognize HMW-BCGF and, conversely, antibodies made to HMWBCGF recognize both intact Factor B and Bb . This is particularly significant in the case of the mAb BCFG-1C2, which inhibits HMW-BCGF binding to B cells (3) . Because this antibody recognizes an epitope on BCGF 1C2 at or near the cell-binding site of the molecule, we examined whether the crossreactive antigen, Factor B, might affect B cell proliferation. We found no effect of intact Factor B, but did find a significant enhancing effect of Bb on B cell proliferation. The effect of Bb shared many characteristics with the known functions of HMW-BCGF. Neither would stimulate unactivated B cells to proliferate, yet both could enhance proliferation of SAC-or anti-IgM-activated B cells. Both exerted their effect primarily on large in vivo preactivated B cells. Both had no effect on Ig secretion when added alone. These data suggest that Bb and HMW-BCGF have functional, as well as antigenic, homology. Because Bb is serine protease, we tested whether its proteolytic activity was required for its effect on B cell proliferation . NPGB, an irreversible serine protease inhibitor, had no effect on the ability of either Bb or HMW-BCGF to induce B cell proliferation. This demonstrated that the effect of Bb on B cells was quite distinct from its effect on monocyte spreading, which clearly is dependent on the protease activity of Bb (21) . We do not believe that Bb acts indirectly on B cell proliferation via stimulation of monocytes because (a) it binds directly to SAC-stimulated B cells and an EBVtransformed B cell line ; (b) preincubation of monocytes with Bb did not lead to enhanced B cell proliferation ; and (c) the activity of Bb on B cells was not inhibited by NPGB.
Because proteolytically inactive Bb affected B cell proliferation, we hypothesized that its effect might be receptor mediated . Bb bound in a saturable manner to B cells, which was consistent with a receptor-mediated event. Although the Kd for Bb binding was rather high, the half maximal biological effect of Bb was in a potentially physiologic range, perhaps suggesting that only a small percent receptor oc- These data raise the possibility that HMW-BCGF is, in fact, Bb. We believe that this is not the case for the following reasons. First, HMWBCGF is synthesized by T cells and some B cell lines, while Factor B is synthesized by monocytes. There is no evidence for its synthesis by lymphocytes of any type. Second, pulse-chase experiments have not suggested a larger molecular weight precursor for HMWBCGF as would be expected ifit were derived from Factor B (12). Since BCGF1C2 recognized intact Factor B, this precursor would have been found if it were present. Finally, although precise quantitation of the HMW-BCGF protein is difficult, estimates of its potency suggest that it induces B cell proliferation at concentrations at least 1,000-fold less than the concentrations of Bb required to induce B cell proliferation. Thus, although there is homology in the cell-binding epitopes ofBb and HMW-BCGF, these are clearly distinct molecules.
The data presented here lead us to hypothesize a new mechanism by which peptides produced at sites of inflammation or infection can affect immune function . Since HMW-BCGF alone does not induce differentiation ofB cells into plasma cells, its primary role in vivo is likely to be to provide a signal for the clonal expansion of antigen-stimulated B cells. Our work suggests that Bb can have a physiologic role similar or identical to HMW-BCGF. Assuming that the concentration of Factor B present at a site of inflammation is approximately equal to serum (2.5 PM), cleavage of only 1-5% of Factor B would achieve concentrations of Bb capable of significant stimulation of the growth of antigen-activated B cells. Thus, Bb could be a signal for the proliferation ofantigen-activated B cells, which is generated early in the inflammatory process. HMW-BCGF, which is synthesized by activated T cells, would not be present until later times after the inflammatory event, and could serve to sustain the clonal expansion of antigen-activated B cells. Other complement components, lymphokines, and inflammatory molecules will also act to regulate B cell function at sites of inflammation . The net effect on B cell physiology would be the sum of a very complex set of stimuli. Nonetheless, this receptor-mediated, nonprotease effect of Bb suggests a mechanism through which complement activation, as part of a nonspecific response to antigenic challenge, can provide an early signal to enhance the antigen-specific immune response.
Summary
The process of B cell growth and differentiation into plasma cells is highly regulated and may be influenced by a large number of inflammatory mediators, including complement components . We have studied the regulatory influence of Bb, a 60-kD peptide created during the cleavage of complement Factor B by Factor D and C3b. Purified Bb alone had no effect on proliferation and differentiation ofhuman splenic or tonsillar B cells . However, when B cells were activated by Staphylococcus aureus Cowan I (SAC), Bb enhanced proliferation in a dose-dependent manner. Bb also enhanced proliferation when cocultured with SAC and suboptimal concentrations of purified 60-kD B cell growth factor (HMW-BCGF), a previously described lymphokine that is known to possess growth-promoting activity. However, Bb had no effect on cells treated with optimal concentrations of HMW-BCGF Like HMW-BCGF, Bb's major effect was on the larger in vivo activated B cells . Half-maximal enhancement of proliferation was reached at a Bb concentration of 1-10 nM. Ofnote is the fact that antibody to Factor B recognized HMW-BCGF, and an mAb to HMW-BCGF also recognized Factor B and Bb, but not Ba. Moreover, radiolabeled Bb bound saturably to activated B cells and to an EBVtransformed human B cell line. The binding of Bb was inhibited by HMW-BCGF but not by Ba or IgG. Thus, Bb is antigenically and functionally related to HMW-BCGF, and can act as a B cell growth and differentiation factor at potentially physiologic concentrations . These data suggest that Bb may be important in amplifying the immune response in areas of inflammation . Since complement activation occurs at inflammatory sites long before induction of HMW-BCGF synthesis, Bb may be an early signal for the clonal expansion of antigenactivated B cells .
